Clorox Q2 net sales +16% to $1.99B; adj. EPS $2.16 vs $0.98 YoY; cyber recovery ahead of schedule

CLOROX CO /DE/

2024-Q2 EPS reported $0.92 revenue$3,376,000,000

Net sales $1.99B, up 16% YoY; organic sales +20% driven by volume rebuild from August cyberattack.
GAAP diluted EPS $0.75 (down 6%) includes $1.04 noncash pension settlement, $0.19 digital investment, $0.16 cyber costs.
Adjusted EPS $2.16, up 120% YoY; gross margin 43.5% (+730 bps) on pricing, cost savings, and volume absorption.
Health & Wellness segment net sales +25% (volume +22%); Household +9%; Lifestyle +21%; International +9%.
YTD operating cash flow $173M (-55%); free cash flow $97M vs $299M prior year.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CLOROX CO /DE/ reported the second quarter of fiscal year 2024, which ended Dec. 31, 2023 results: EPS 75 cents.

Period: the second quarter of fiscal year 2024, which ended Dec. 31, 2023
EPS: 75 cents
Result: reported results

Exact text from the filing

On February 1, 2024 , The Clorox Company issued a press release announcing its financial results for its second quarter ended December 31, 2023.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

CLOROX CO /DE/ filing history →

Source: SEC EDGAR

accession 0000021076-24-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.